In this study, it has been demonstrated by the TCGA database and qRT-PCR assay that DUXAP8 is expressed at lower levels in AML, and AML patients with low DUXAP8 expression showed worse prognosis. Here, DUXAP8 is linked to acute myeloid leukemia.